S&P 500   4,124.44 (-0.95%)
DOW   33,998.01 (-0.46%)
QQQ   305.33 (-1.47%)
AAPL   152.23 (-1.56%)
MSFT   269.67 (+0.79%)
META   185.19 (-3.36%)
GOOGL   99.09 (-7.94%)
AMZN   99.56 (-2.50%)
TSLA   200.78 (+2.02%)
NVDA   223.59 (+0.84%)
NIO   10.72 (-1.83%)
BABA   106.29 (+0.75%)
AMD   85.36 (-0.64%)
T   19.08 (-0.88%)
F   13.48 (+0.22%)
MU   60.81 (-2.12%)
CGC   2.78 (-1.42%)
GE   81.90 (-0.26%)
DIS   111.03 (-0.54%)
AMC   5.76 (-6.80%)
PFE   43.79 (+0.46%)
PYPL   80.30 (-3.52%)
NFLX   361.87 (-0.30%)
S&P 500   4,124.44 (-0.95%)
DOW   33,998.01 (-0.46%)
QQQ   305.33 (-1.47%)
AAPL   152.23 (-1.56%)
MSFT   269.67 (+0.79%)
META   185.19 (-3.36%)
GOOGL   99.09 (-7.94%)
AMZN   99.56 (-2.50%)
TSLA   200.78 (+2.02%)
NVDA   223.59 (+0.84%)
NIO   10.72 (-1.83%)
BABA   106.29 (+0.75%)
AMD   85.36 (-0.64%)
T   19.08 (-0.88%)
F   13.48 (+0.22%)
MU   60.81 (-2.12%)
CGC   2.78 (-1.42%)
GE   81.90 (-0.26%)
DIS   111.03 (-0.54%)
AMC   5.76 (-6.80%)
PFE   43.79 (+0.46%)
PYPL   80.30 (-3.52%)
NFLX   361.87 (-0.30%)
S&P 500   4,124.44 (-0.95%)
DOW   33,998.01 (-0.46%)
QQQ   305.33 (-1.47%)
AAPL   152.23 (-1.56%)
MSFT   269.67 (+0.79%)
META   185.19 (-3.36%)
GOOGL   99.09 (-7.94%)
AMZN   99.56 (-2.50%)
TSLA   200.78 (+2.02%)
NVDA   223.59 (+0.84%)
NIO   10.72 (-1.83%)
BABA   106.29 (+0.75%)
AMD   85.36 (-0.64%)
T   19.08 (-0.88%)
F   13.48 (+0.22%)
MU   60.81 (-2.12%)
CGC   2.78 (-1.42%)
GE   81.90 (-0.26%)
DIS   111.03 (-0.54%)
AMC   5.76 (-6.80%)
PFE   43.79 (+0.46%)
PYPL   80.30 (-3.52%)
NFLX   361.87 (-0.30%)
S&P 500   4,124.44 (-0.95%)
DOW   33,998.01 (-0.46%)
QQQ   305.33 (-1.47%)
AAPL   152.23 (-1.56%)
MSFT   269.67 (+0.79%)
META   185.19 (-3.36%)
GOOGL   99.09 (-7.94%)
AMZN   99.56 (-2.50%)
TSLA   200.78 (+2.02%)
NVDA   223.59 (+0.84%)
NIO   10.72 (-1.83%)
BABA   106.29 (+0.75%)
AMD   85.36 (-0.64%)
T   19.08 (-0.88%)
F   13.48 (+0.22%)
MU   60.81 (-2.12%)
CGC   2.78 (-1.42%)
GE   81.90 (-0.26%)
DIS   111.03 (-0.54%)
AMC   5.76 (-6.80%)
PFE   43.79 (+0.46%)
PYPL   80.30 (-3.52%)
NFLX   361.87 (-0.30%)
NASDAQ:SGRY

Surgery Partners - SGRY Stock Forecast, Price & News

$33.41
-0.39 (-1.15%)
(As of 02/8/2023 12:14 PM ET)
Add
Compare
Today's Range
$33.10
$34.01
50-Day Range
$25.41
$35.94
52-Week Range
$20.46
$63.87
Volume
202,270 shs
Average Volume
635,341 shs
Market Capitalization
$3.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$42.33

Surgery Partners MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.71 Rating Score
Upside/​Downside
26.3% Upside
$42.33 Price Target
Short Interest
Bearish
8.78% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.36mentions of Surgery Partners in the last 14 days
Based on 8 Articles This Week
Insider Trading
Acquiring Shares
$245,000 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.10) to $0.33 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

323rd out of 1,029 stocks

General Medical & Surgical Hospitals Industry

4th out of 5 stocks

SGRY stock logo

About Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Stock News Headlines

Huge Upside Potential With "Staggering" Solar Demand
Global solar demand is "staggering" right now, according to Bloomberg. Solar installations are set to grow 30% this year alone. And the boom is just beginning, with increasing adoption of solar by commercial, non-profit, and public entities. With only 1% of commercial electricity demand served by on-site solar globally, there is HUGE opportunity for growth.
Analyst Expectations for Surgery Partners's Future
Surgery Partners reaffirms FY22 guidance
The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
Board Member of Surgery Partners Makes $225.00M Buy
Surgery Partners Commences Public Offering Of Common Stock - Quick Facts
See More Headlines
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Company Calendar

Last Earnings
11/02/2021
Today
2/08/2023
Next Earnings (Estimated)
2/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
General medical & surgical hospitals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SGRY
Employees
10,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$42.33
High Stock Price Forecast
$56.00
Low Stock Price Forecast
$35.00
Forecasted Upside/Downside
+26.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.71
Research Coverage
7 Analysts

Profitability

Net Income
$-70,900,000.00
Pretax Margin
5.40%

Debt

Sales & Book Value

Annual Sales
$2.23 billion
Cash Flow
$0.99 per share
Book Value
$22.05 per share

Miscellaneous

Free Float
86,983,000
Market Cap
$3.01 billion
Optionable
Optionable
Beta
2.71

Key Executives

  • J. Eric Evans
    Chief Executive Officer & Director
  • David T. DohertyDavid T. Doherty
    Chief Financial Officer & Executive Vice President
  • Varun Gadhok
    Chief Information Officer & Senior Vice President
  • Roxanne Womack
    Chief Compliance Officer & Senior Vice President
  • Jennifer B. BaldockJennifer B. Baldock
    Secretary, Chief Administrative Officer & EVP













SGRY Stock - Frequently Asked Questions

Should I buy or sell Surgery Partners stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SGRY shares.
View SGRY analyst ratings
or view top-rated stocks.

What is Surgery Partners' stock price forecast for 2023?

7 Wall Street research analysts have issued 1-year price objectives for Surgery Partners' stock. Their SGRY share price forecasts range from $35.00 to $56.00. On average, they predict the company's share price to reach $42.33 in the next twelve months. This suggests a possible upside of 26.0% from the stock's current price.
View analysts price targets for SGRY
or view top-rated stocks among Wall Street analysts.

How have SGRY shares performed in 2023?

Surgery Partners' stock was trading at $27.86 at the beginning of the year. Since then, SGRY shares have increased by 20.6% and is now trading at $33.61.
View the best growth stocks for 2023 here
.

When is Surgery Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our SGRY earnings forecast
.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) issued its earnings results on Tuesday, November, 2nd. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.04. The business earned $559.20 million during the quarter, compared to the consensus estimate of $554.15 million. Surgery Partners had a negative trailing twelve-month return on equity of 0.51% and a negative net margin of 1.28%. During the same quarter last year, the firm earned ($0.59) earnings per share.

What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners issued an update on its FY 2022 earnings guidance on Friday, January, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.50 billion-$2.55 billion, compared to the consensus revenue estimate of $2.52 billion.

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Surgery Partners own?
What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Cannell & Co. (0.58%), WCM Investment Management LLC (0.43%), Bank of Montreal Can (0.25%), Rheos Capital Works Inc. (0.19%), Sivik Global Healthcare LLC (0.18%) and Swiss National Bank (0.18%). Insiders that own company stock include Anthony Taparo, Brent Turner, David T Doherty, George Goodwin, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt.
View institutional ownership trends
.

How do I buy shares of Surgery Partners?

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $33.61.

How much money does Surgery Partners make?

Surgery Partners (NASDAQ:SGRY) has a market capitalization of $3.02 billion and generates $2.23 billion in revenue each year. The company earns $-70,900,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis.

How many employees does Surgery Partners have?

The company employs 10,900 workers across the globe.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The official website for the company is www.surgerypartners.com. The company can be reached via phone at (615) 234-5900, via email at ir@surgerypartners.com, or via fax at 615-234-5998.

This page (NASDAQ:SGRY) was last updated on 2/8/2023 by MarketBeat.com Staff